223 related articles for article (PubMed ID: 15040940)
1. Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide.
Maira-Litran T; Kropec A; Goldmann D; Pier GB
Vaccine; 2004 Feb; 22(7):872-9. PubMed ID: 15040940
[TBL] [Abstract][Full Text] [Related]
2. The role of epitope specificity in the human opsonic antibody response to the staphylococcal surface polysaccharide poly N-acetyl glucosamine.
Kelly-Quintos C; Kropec A; Briggs S; Ordonez CL; Goldmann DA; Pier GB
J Infect Dis; 2005 Dec; 192(11):2012-9. PubMed ID: 16267775
[TBL] [Abstract][Full Text] [Related]
3. Poly-N-acetylglucosamine is not a major component of the extracellular matrix in biofilms formed by icaADBC-positive Staphylococcus lugdunensis isolates.
Frank KL; Patel R
Infect Immun; 2007 Oct; 75(10):4728-42. PubMed ID: 17635864
[TBL] [Abstract][Full Text] [Related]
4. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.
Maira-Litrán T; Kropec A; Goldmann DA; Pier GB
Infect Immun; 2005 Oct; 73(10):6752-62. PubMed ID: 16177353
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine.
Cerca N; Jefferson KK; Maira-Litrán T; Pier DB; Kelly-Quintos C; Goldmann DA; Azeredo J; Pier GB
Infect Immun; 2007 Jul; 75(7):3406-13. PubMed ID: 17470540
[TBL] [Abstract][Full Text] [Related]
6. A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model.
Kuklin NA; Clark DJ; Secore S; Cook J; Cope LD; McNeely T; Noble L; Brown MJ; Zorman JK; Wang XM; Pancari G; Fan H; Isett K; Burgess B; Bryan J; Brownlow M; George H; Meinz M; Liddell ME; Kelly R; Schultz L; Montgomery D; Onishi J; Losada M; Martin M; Ebert T; Tan CY; Schofield TL; Nagy E; Meineke A; Joyce JG; Kurtz MB; Caulfield MJ; Jansen KU; McClements W; Anderson AS
Infect Immun; 2006 Apr; 74(4):2215-23. PubMed ID: 16552052
[TBL] [Abstract][Full Text] [Related]
7. Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy.
Skurnik D; Kropec A; Roux D; Theilacker C; Huebner J; Pier GB
Clin Infect Dis; 2012 Nov; 55(9):1188-97. PubMed ID: 22806596
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapeutic strategies to combat staphylococcal infections.
Ohlsen K; Lorenz U
Int J Med Microbiol; 2010 Aug; 300(6):402-10. PubMed ID: 20547101
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
Maira-Litrán T; Bentancor LV; Bozkurt-Guzel C; O'Malley JM; Cywes-Bentley C; Pier GB
PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144
[TBL] [Abstract][Full Text] [Related]
10. Immunity induced by Staphylococcus aureus surface protein A was protective against lethal challenge of Staphylococcus aureus in BALB/c mice.
Yi SQ; Zhang XY; Yang YL; Yang Y; Liu SL; Fu L; Yu CM; Chen W
Microbiol Immunol; 2012 Jun; 56(6):406-10. PubMed ID: 22420921
[TBL] [Abstract][Full Text] [Related]
11. Vaccination and passive immunisation against Staphylococcus aureus.
Schaffer AC; Lee JC
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S71-8. PubMed ID: 18757184
[TBL] [Abstract][Full Text] [Related]
12. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus aureus antigens and challenges in vaccine development.
Middleton JR
Expert Rev Vaccines; 2008 Aug; 7(6):805-15. PubMed ID: 18665778
[TBL] [Abstract][Full Text] [Related]
14. Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials.
Fattom AI; Horwith G; Fuller S; Propst M; Naso R
Vaccine; 2004 Feb; 22(7):880-7. PubMed ID: 15040941
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive synthetic library of poly-N-acetyl glucosamines enabled vaccine against lethal challenges of Staphylococcus aureus.
Tan Z; Yang W; O'Brien NA; Pan X; Ramadan S; Marsh T; Hammer N; Cywes-Bentley C; Vinacur M; Pier GB; Gildersleeve JC; Huang X
Nat Commun; 2024 Apr; 15(1):3420. PubMed ID: 38658531
[TBL] [Abstract][Full Text] [Related]
16. Clonal relatedness of methicillin-resistant coagulase-negative staphylococci in the haemodialysis unit of a single university centre in Greece.
Liakopoulos V; Petinaki E; Efthimiadi G; Klapsa D; Giannopoulou M; Dovas S; Eleftheriadis T; Mertens PR; Stefanidis I
Nephrol Dial Transplant; 2008 Aug; 23(8):2599-603. PubMed ID: 18305314
[TBL] [Abstract][Full Text] [Related]
17. Diversity and evolution of blaZ from Staphylococcus aureus and coagulase-negative staphylococci.
Olsen JE; Christensen H; Aarestrup FM
J Antimicrob Chemother; 2006 Mar; 57(3):450-60. PubMed ID: 16449305
[TBL] [Abstract][Full Text] [Related]
18. Vaccine potential of poly-1-6 beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis.
Mckenney D; Pouliot K; Wang Y; Murthy V; Ulrich M; Döring G; Lee JC; Goldmann DA; Pier GB
J Biotechnol; 2000 Sep; 83(1-2):37-44. PubMed ID: 11000458
[TBL] [Abstract][Full Text] [Related]
19. Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines.
Broughan J; Anderson R; Anderson AS
Expert Rev Vaccines; 2011 May; 10(5):695-708. PubMed ID: 21604989
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine.
Kelly-Quintos C; Cavacini LA; Posner MR; Goldmann D; Pier GB
Infect Immun; 2006 May; 74(5):2742-50. PubMed ID: 16622211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
